Target intelligence / Profile preview

PRELI domain containing 2 (PRELID2)

Target
PRELID2
Molecular classification
Other (PRELI/MSF1 domain-containing protein), Mitochondrial lipid transfer protein
01

Overview

PRELI domain containing 2 (PRELID2) is a protein coding gene in humans, predominantly recognized for its predicted function in phosphatidic acid transfer activity and involvement in phospholipid transport within the mitochondrial intermembrane space[4][6]. As a member of the PRELI/MSF1 domain-containing protein family, PRELID2 is evolutionarily conserved and implicated in mitochondrial lipid metabolism, a process crucial for maintaining cellular energy homeostasis and membrane dynamics[2][4]. Functional studies on the PRELI-like family suggest roles in embryogenesis, lymphocyte differentiation, and stress responses, with recent evidence indicating its association with cancer progression, including potential contributions to radiotherapy resistance and tumor microenvironment adaptation[2][6]. No directly approved drugs or therapeutics specifically target PRELID2, although family members are of interest as potential cancer biomarkers and future therapeutic targets.

Other names
PRELI domain-containing protein 2MGC21644FLJ38376CTC-806A22.1
02

Biological functions

Phosphatidic acid transfer activityPhospholipid transportPossible roles in mitochondrial lipid homeostasis
03

Disease associations

Cancer (suggested involvement in tumor progression and therapy resistance, e.g., nasopharyngeal carcinoma, renal cell carcinoma)Other (general role in cellular metabolic processes, especially mitochondrial function)
04

Biomarkers

Possible use as biomarker for therapy resistance in head and neck squamous cell carcinoma (HNSCC)Circular RNA from PRELID2 (circPRELID2) may serve as a biomarker in renal cell carcinoma

Beyond the preview

Go deeper on PRELI domain containing 2 (PRELID2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRELI domain containing 2 (PRELID2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call